New app could bridge the gap between HIV Self-Testing and PrEP access
NCT ID NCT07614165
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a mobile-friendly app called DASH that provides information and guidance about PrEP (a daily pill that prevents HIV) to people who have used an HIV self-test kit. The app helps users explore their values and make informed decisions about starting PrEP, with links to local or online resources. Researchers will enroll 170 HIV-negative adults aged 18-39 who have never used PrEP, and compare PrEP uptake at 3 months between those who use the app and those who don't.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PrEP Decisional Aid mobile app (DASH)
What this could lead to
If successful, this app could become a simple, scalable way to connect HIV self-test users with PrEP, helping more people access effective HIV prevention.
What could go wrong
This is a small pilot study (170 people) testing a behavioral tool, not a drug. The app may not significantly increase PrEP use, and results may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PRE-EXPOSURE PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States